Skip to main content
OpenTrials
Completed

NCT Number: NCT07102810

Hypnosis-Based Machine Learning Biomarker Study

This study seeks to contribute to the growing body of literature on hypnosis by providing robust, data-driven insights into the physiological mechanisms underlying trance states. The integration of electroencephalogram (EEG) and other wearable-derived physiological data will offer a comprehensive assessment of the changes that occur during a standardized hypnosis protocol: the Harvard Group Scale of Hypnotic Susceptibility (HGSHS:A). The results of this study are intended to facilitate derivation and validation of an Artificial Intelligence/Machine Learning (AI/ML)-based monitor that quantifies a patient's instantaneous emotional/arousal state along the spectrum that spans anxiety through states of calmness and trance. Future investigations will explore the ability of using such an interactive virtual system as a component of a closed-loop adaptive device to create optimal states of non-pharmacological sedation using personalized audiovisual content to allay anxiety and discomfort during medical procedures, such as percutaneous biopsies.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mount Sinai Hospital

New York, 10029, United States

About this study

This is an interventional study that will acquire data to characterize the time course of physiological biomarkers and audiovisual observations of depth of trance before, during and upon emergence from a standardized hypnotic susceptibility protocol. The subjects will also complete the State Trait Anxiety Inventory (STAI) immediately before and after the hypnosis protocol. The differences in the biomarker signals among subjects of different degrees of hypnotic susceptibility and different pre-post levels of state anxiety will facilitate between- and within-subjects comparisons that will be supplemented by computer vision analysis of subject responses. The full data set will be used to facilitate derivation and validation of a novel machine-learning monitoring tool to measure instantaneous emotional/arousal levels along a spectrum that spans anxiety through calmness and trance.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent obtained from participant and ability and willingness for participant to comply with the requirements of the study.
  • Adults of all genders, ages 18-65
  • Healthy volunteers
  • English-speaking

Exclusion criteria

  • Participating currently in experimental drug trials.
  • Recent (<1 year) or current history of substance use disorder.
  • Diabetes T1 or T2, major cardiovascular or respiratory diseases, major neurological diseases, or limited mobility
  • Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the patient or the quality of the data.
  • Adults that cannot consent.
  • Chronic use of psychoactive medications.
  • Chronic use of antiepileptic medications.
  • Active substance use disorder.
  • Participants reporting significant phobias or anxiety disorders triggered by imagery or situations involving insects (specifically flies), enclosed spaces or elevators (claustrophobia), or heights (acrophobia).

Treatment and study plan

Standardized Hypnotic Susceptibility Testing

Behavioral

Participants will be guided through the Harvard Group Scale of Hypnotic Susceptibility: Form A (HGSHS:A), a validated group hypnosis protocol that includes standardized hypnotic inductions and suggestibility tasks.

Other names: HGSHS:A

Primary outcomes

  1. Harvard Group Scale of Hypnotic Susceptibility (HGSHS:A) Total Score

    Time frame: During hypnosis session (single study visit)

    Total score (0-12) reflecting responsiveness to hypnotic suggestion during standardized protocol. Higher scores suggest greater responsiveness to hypnotic suggestion.

Secondary outcomes

  1. State-Trait Anxiety Inventory (STAI) Subscale Scores

    Time frame: Immediately Pre- and immediately post-hypnosis session (single study visit)

    The State-Trait Anxiety Inventory is a 40-item instrument divided into two subscales: state and trait anxiety. State Subscale range from 20-80, with higher score suggesting more anxiety at a particular moment in time. Trait Subscale range from 20-80, with higher score suggesting general anxiety feelings overall. These will not be summed therefore there will not be one total scale.

  2. EEG Spectral Power

    Time frame: Immediately Pre-, During, and immediately post-hypnosis session (single study visit)

    Power values in EEG frequency bands collected across 21 electrodes during baseline, hypnotic induction, and post-session phases.

  3. Heart Rate (HR)

    Time frame: Immediately Pre-, During, and immediately post-hypnosis session (single study visit)

    Mean heart rate (beats per minute) captured continuously using a wearable chest patch before, during, and after hypnosis session.

  4. Heart Rate Variability (HRV)

    Time frame: Immediately Pre-, During, and immediately post-hypnosis session (single study visit)

    Time and frequency domain HRV metrics derived from wearable ECG data.

  5. Respiratory Rate (RR)

    Time frame: Immediately Pre-, During, and immediately post-hypnosis session (single study visit)

    Mean respiratory rate (breaths per minute) obtained from a respiration belt and ECG-derived signals.

  6. Electrodermal Activity (EDA)

    Time frame: Immediately Pre-, During, and immediately post-hypnosis session (single study visit)

    Skin conductance level and phasic response rate measured using BIOPAC sensors.

  7. Pre-Ejection Period (PEP)

    Time frame: Immediately Pre-, During, and immediately post-hypnosis session (single study visit)

    Pre-ejection period (ms), a marker of sympathetic nervous system activity, measured via seismocardiogram from chest patch.

  8. Respiratory Sinus Arrhythmia (RSA)

    Time frame: Immediately Pre-, During, and immediately post-hypnosis session (single study visit)

    RSA index (ms²), derived from heart rate and respiration synchrony during hypnotic protocol.

Sponsors and collaborators

Lead sponsor

Icahn School of Medicine at Mount Sinai

Other

Collaborators

  • Entrancing Entertainment, Inc.

Registry information

Official study title

Standardized Hypnotic Susceptibility Testing to Facilitate Development of a Machine Learning Tool to Characterize Physiological Biomarkers of Calm and Tranced States

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 5, 2025
Registry last updated
Sep 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.